These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25475747)

  • 21. Human-Specific Abnormal Alternative Splicing of Wild-Type
    Lea WA; Parnell SC; Wallace DP; Calvet JP; Zelenchuk LV; Alvarez NS; Ward CJ
    J Am Soc Nephrol; 2018 Oct; 29(10):2482-2492. PubMed ID: 30185468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retromer associates with the cytoplasmic amino-terminus of polycystin-2.
    Tilley FC; Gallon M; Luo C; Danson CM; Zhou J; Cullen PJ
    J Cell Sci; 2018 Jun; 131(11):. PubMed ID: 29724910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single amino acid residue constitutes the third dimerization domain essential for the assembly and function of the tetrameric polycystin-2 (TRPP2) channel.
    Feng S; Rodat-Despoix L; Delmas P; Ong AC
    J Biol Chem; 2011 May; 286(21):18994-9000. PubMed ID: 21474446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic kidney disease: novel insights into polycystin function.
    Luo L; Roy S; Li L; Ma M
    Trends Mol Med; 2023 Apr; 29(4):268-281. PubMed ID: 36805211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperphosphorylation of polycystin-2 at a critical residue in disease reveals an essential role for polycystin-1-regulated dephosphorylation.
    Streets AJ; Wessely O; Peters DJ; Ong AC
    Hum Mol Genet; 2013 May; 22(10):1924-39. PubMed ID: 23390129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Myc is a regulator of the PKD1 gene and PC1-induced pathogenesis.
    Parrot C; Kurbegovic A; Yao G; Couillard M; Côté O; Trudel M
    Hum Mol Genet; 2019 Mar; 28(5):751-763. PubMed ID: 30388220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
    Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
    Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the polycystin-1 C-terminal cytoplasmic tail increases Cl channel activity in Xenopus oocytes.
    Chernova MN; Vandorpe DH; Clark JS; Alper SL
    Kidney Int; 2005 Aug; 68(2):632-41. PubMed ID: 16014040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.
    Aguiari G; Banzi M; Gessi S; Cai Y; Zeggio E; Manzati E; Piva R; Lambertini E; Ferrari L; Peters DJ; Lanza F; Harris PC; Borea PA; Somlo S; Del Senno L
    FASEB J; 2004 May; 18(7):884-6. PubMed ID: 15001556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Divergent function of polycystin 1 and polycystin 2 in cell size regulation.
    Viau A; Kotsis F; Boehlke C; Braeg S; Klein M; Nitschke R; Walz G; Kuehn EW
    Biochem Biophys Res Commun; 2020 Jan; 521(2):290-295. PubMed ID: 31668373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A tale of two tails: ciliary mechanotransduction in ADPKD.
    Cantiello HF
    Trends Mol Med; 2003 Jun; 9(6):234-6. PubMed ID: 12829010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TRPP2 dysfunction decreases ATP-evoked calcium, induces cell aggregation and stimulates proliferation in T lymphocytes.
    Magistroni R; Mangolini A; Guzzo S; Testa F; Rapanà MR; Mignani R; Russo G; di Virgilio F; Aguiari G
    BMC Nephrol; 2019 Sep; 20(1):355. PubMed ID: 31514750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.
    Bastos AP; Onuchic LF
    Braz J Med Biol Res; 2011 Jul; 44(7):606-17. PubMed ID: 21625823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy.
    Paavola J; Schliffke S; Rossetti S; Kuo IY; Yuan S; Sun Z; Harris PC; Torres VE; Ehrlich BE
    J Mol Cell Cardiol; 2013 May; 58():199-208. PubMed ID: 23376035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
    Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
    Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polycystin-1 dysfunction impairs electrolyte and water handling in a renal precystic mouse model for ADPKD.
    Verschuren EHJ; Mohammed SG; Leonhard WN; Overmars-Bos C; Veraar K; Hoenderop JGJ; Bindels RJM; Peters DJM; Arjona FJ
    Am J Physiol Renal Physiol; 2018 Sep; 315(3):F537-F546. PubMed ID: 29767557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystin-1, the product of the polycystic kidney disease gene PKD1, is post-translationally modified by palmitoylation.
    Roy K; Marin EP
    Mol Biol Rep; 2018 Oct; 45(5):1515-1521. PubMed ID: 30073588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure and function of polycystins: insights into polycystic kidney disease.
    Douguet D; Patel A; Honoré E
    Nat Rev Nephrol; 2019 Jul; 15(7):412-422. PubMed ID: 30948841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease.
    Chebib FT; Jung Y; Heyer CM; Irazabal MV; Hogan MC; Harris PC; Torres VE; El-Zoghby ZM
    Nephrol Dial Transplant; 2016 Jun; 31(6):952-60. PubMed ID: 26932689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.